- Home
- DHC vs PHAR Comparison
DHC vs PHAR Comparison
Compare DHC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHC
- PHAR
- Stock Information
- Founded
- DHC 1998
- PHAR 1988
- Country
- DHC United States
- PHAR Netherlands
- Employees
- DHC N/A
- PHAR N/A
- Industry
- DHC Real Estate Investment Trusts
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- DHC Real Estate
- PHAR Health Care
- Exchange
- DHC Nasdaq
- PHAR Nasdaq
- Market Cap
- DHC 559.7M
- PHAR 587.5M
- IPO Year
- DHC N/A
- PHAR N/A
- Fundamental
- Price
- DHC $3.02
- PHAR $10.03
- Analyst Decision
- DHC Hold
- PHAR Strong Buy
- Analyst Count
- DHC 3
- PHAR 3
- Target Price
- DHC $4.50
- PHAR $30.00
- AVG Volume (30 Days)
- DHC 923.8K
- PHAR 3.0K
- Earning Date
- DHC 05-05-2025
- PHAR 05-08-2025
- Dividend Yield
- DHC 1.34%
- PHAR N/A
- EPS Growth
- DHC N/A
- PHAR N/A
- EPS
- DHC N/A
- PHAR N/A
- Revenue
- DHC $1,511,515,000.00
- PHAR $320,708,000.00
- Revenue This Year
- DHC $5.12
- PHAR $12.39
- Revenue Next Year
- DHC $6.23
- PHAR $9.84
- P/E Ratio
- DHC N/A
- PHAR N/A
- Revenue Growth
- DHC 5.33
- PHAR 24.13
- 52 Week Low
- DHC $2.00
- PHAR $6.65
- 52 Week High
- DHC $4.24
- PHAR $11.07
- Technical
- Relative Strength Index (RSI)
- DHC 74.73
- PHAR 71.76
- Support Level
- DHC $2.15
- PHAR $8.60
- Resistance Level
- DHC $3.14
- PHAR $10.28
- Average True Range (ATR)
- DHC 0.17
- PHAR 0.30
- MACD
- DHC 0.10
- PHAR 0.17
- Stochastic Oscillator
- DHC 87.88
- PHAR 88.79
About DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.